The Infinnium® Paclitaxel Eluting Stent features a biodegradable polymer that is fully absorbed after 7 months. The proven drug Paclitaxel selectively inhibits smooth muscles cells* and thus favors rapid re-endothelialization.
*Limus drugs inhibit both smooth muscle cells AND endothelial cells.
Key Features*:
> complete Paclitaxel elution in 48 days
> competitive late lumen loss:
in-stent 0.38 mm, in-segment 0.18 mm @ 9M
> no residual polymer after 7 months
> low crossing profile: 0.036" for 3.0 mm
The Irist® DES is the first stent eluting the non-toxic drug simvastatin. Together with its anti-inflammatory P-5 triflusal based polymer the Irist® DES is designed for maximum DES safety.
Key Features*:
> complete simvastatin elution in 70 days
> MACE 7.1 %, TLR 4.3 % @ 9M
> binary restenosis 4.5 % @ 9M
> in-stent late lumen loss 0.63 mm @ 9M
*
